Clinical Trial

ITP Registry and Accompanying Biospecimen Collection

Study acronym: ITP-Registry
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this ITP registry is to collect clinical information, including biosampling, from consenting patients with a variety of ITPs at different points in the course of their disease.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-12-07; most recent amendment 2025-07-10.
Status change: Not Yet Recruiting → Recruiting 2022-03-29
Trial Details
NCT Number NCT05152238
Lead Sponsor Jena University Hospital
Collaborators: University Hospital Dresden, Novartis, Swedish Orphan Biovitrum, Grifols Biologicals, LLC, Amgen, argenx
Conditions Immune Thrombocytopenia
Enrollment 1,100 participants
Start Date 2021-11-29
Primary Completion 2026-09 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2025-07-15